| |
|
Vivek Rao, MSc, FRCSC, PhD, MD
|
Senior Scientist Division of Experimental Therapeutics - Cardiovascular Toronto General Research Institute (TGRI) |
Keywords: heart failure, endothelial function, surgery for end-stage heart disease, transplant vasculopathy, mechanical circulatory support
|
- Myocardial preservation for heart transplantation
- Ventricular recovery during mechanical circulatory support
- Influence of aortic valve size on survival following AVR
- Cell transplantation for end-stage heart disease
- Molecular mechanisms underlying transplant coronary artery disease
Additional Appointments
- Site Leader, Medical Technology Innovation Priority Platform (TGRI)
|
Pubmed Publications | | | |
Selected Publications | - Mitesh V. Badiwala, Subodh Verma, Vivek Rao. Surgical management of ischemic mitral regurgitation. Circulation 2009; 120: 1287-1293.
- Mitesh V. Badiwala, Danny Ramzy, Laura C. Tumiati, Elissa Tepperman, Rohit Sheshgiri, Jessica Prodger, Christopher M. Feindel, Vivek Rao. Donor pretreatment with hypertonic saline attenuates primary allograft dysfunction. Circulation 2009; 120: S206-214.
- Rohit Sheshgiri, Vivek Rao, Laura C. Tumiati, Rong Xiao, Jessica Prodger, Mitesh Badiwala, Clifford Librach, Diego H. Delgado. Progesterone induces human leukocyte antigen-G expression in vascular endothelial and smooth muscle cells. Circulation 2008; 118: S58-64.
- Rohit Sheshgiri, Vivek Rao, Jagdish Butany, Danny Ramzy, Nathalie Rouas-Feiss, Irene Krawice-Radanne, Heather J. Ross, Eduardo D. Carosella, Diego H. Delgado. Myocardial Human Leukocyte Antigen-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2008; 27: 522-527.
- Mitesh Badiwala, Vivek Rao, Heather J. Ross. An unusual and fatal complication of mechanical circulatory support with a continuous flow assist device. New Engl J Med 2007; 357: 936-937.
| | |
| |
|
|

|
Primary LAB Toronto General Hospital Eaton North Wing 4th Floor Rm 4N457 200 Elizabeth St. Toronto, Ontario Canada M5G 2C4 |
| |
|

|
|
| 416-340-3562 | (Primary) | | 416-340-3337 | (FAX) |
|
|